Psychedelic Business Spotlight: November 5
Business, Stock Reports
This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.
Leave a Reply
Want to join the discussion?Feel free to contribute!